Neuland Laboratories Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 9 Fair Values set on narratives written by author
₹17,067.90
5392.00 (46.18%)
9.5% undervalued intrinsic discount
₹18,852.75
Fair Value
Price ₹17,067.90
AnalystConsensusTarget ₹18,852.75
Fair Value₹20,972.00
Share Pricen/a
524558 Community Narratives
AN
Fair Value
·Fair Value ₹20.97k 18.6% undervalued intrinsic discount
524558: Leadership Changes And Board Decisions Will Shape The Next Phase
1users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
524558: Leadership Changes And Board Decisions Will Shape The Next Phase
Key Takeaways Expansion of manufacturing capacity and complex API focus will enhance revenue momentum, margins, and client acquisition as industry shifts supply chains away from traditional sources. Investments in advanced manufacturing, site expansion, and automation are set to improve cost efficiencies, working capital, and global competitiveness.Read more
AN

₹20.97k
18.6% undervalued intrinsic discount
Fair Value
Revenue
19.15% p.a.
Profit Margin
21%
Future PE
49.87x
Price in 2029
₹27.96k
Trending Discussion
Recently Updated Narratives
AN
524558: New CEO And CDMO Focus Will Support Future Upside Potential
Fair Value: ₹20.97k 18.6% undervalued intrinsic discount
4 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Neuland Laboratories Limited Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
- 283.71
- 53.18%
- 17.99%
- 10.5%
About 524558
- Founded
- 1984
- Employees
- 1794
- CEO
- Website
View website
Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.